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2015 Annual Report for the Emerging Infections Program for Clostridium difficile Infection
In 2015, a total of 17,354 cases of C. difficile infection (CDI) were reported to the Emerging Infections Program
(EIP) in 35 counties in 10 US states (California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New
Mexico, New York, Oregon, and Tennessee).
The overall distribution of EIP CDI cases and crude incidence by selected demographic factors and epidemiologic
classification are presented in Table 1. Data in this report are not intended to be directly compared to annual
reports from other years, and should not be used to determine annual changes in EIP CDI incidence rates
because single year calculations do not account for changes in testing practices by reporting facilities.
Table 1. Reported Number of CDI Cases and Crude Incidence by Sex, Age Group, Race, and Epidemiologic
Classification Among the 10 EIP Sitesa
Demographic
Characteristic
Population ≥1
Year of Age
Community Associated
CDIb
Healthcare Associated
CDIb
All CDI
No. Incidencec No. Incidencec No. Incidencec 
Sex
Male 5717797 2787 48.74 4305 75.29 7092 124.03
Female 5964630 4901 82.17 5361 89.88 10262 172.05
Age group
1-17 years 2537415 595 23.45 189 7.45 784 30.90
18-44 years 4580200 1964 42.88 1136 24.80 3100 67.68
45-64 years 3064141 2412 78.72 2667 87.04 5079 165.76
≥65 years 1500671 2717 181.05 5674 378.10 8391 559.15
Race 
White 7979542 6116 76.65 7054 88.40 13170 165.05
Non-white 3702885 1572 42.45 2612 70.54 4184 112.99
Total 11682427 7688 65.81 9666 82.74 17354 148.55
a The epidemiologic classification was statistically imputed for 0.9% of the observed CDI cases, and race was
statistically imputed for 16.8% of the observed CDI cases. The weighted frequency of cases in Colorado and
Georgia was based on 33% random sampling.
b A CDI case was classified as community-associated if the C. difficile-positive stool specimen was collected on an
outpatient basis or within 3 days after hospital admission in a person with no documented overnight stay in a 
healthcare facility in the preceding 12 weeks. All CDI cases that do not meet the aforementioned criteria were
classified as healthcare-associated.
c Cases per 100,000 persons.
Laboratory Characterization of C. difficile Isolates
In 2015, a total of 1,152 C. difficile isolates were submitted to CDC for further analysis. The total number of 
isolates received from each site ranged from 61 to 279, with a median of 99. The majority of the isolates (88%)
were collected in metropolitan areas.
Among all isolates submitted, 133 distinct ribotypes were detected. Ribotype 106 was the most common
ribotype among community-associated C. difficile isolates, followed by 027, 014 and 020 (Table 2). Among
healthcare-associated C. difficile isolates, ribotype 027 predominated, followed by 106, 002 and 014 (Table 3).
An increase in ribotype 027 occurred from 14% in 2014 to 19% in 2015 among healthcare-associated C. difficile
isolates, although it was not statistically significant (p=0.08). Ribotype 027 remained relatively stable among
community-associated C. difficile isolates between 2014 (7%) and 2015 (8%).
Accessible version: https://www.cdc.gov/hai/eip/Annual-CDI-Report-2015.html
                
           
 
      
    
   
   
   
   
   
   
   
   
   
   
      
   
   
   
   
   
   
   
   
   
   
   
      
      
      
     
Twenty-six percent of the isolates harbored a deletion in tcdC. Twenty-six percent of the isolates were binary
toxin-positive, and among these, ribotypes 027, 153_251, and 078 predominated.
Table 2. Frequency of Ribotypes Among Community- Table 3. Frequency of Ribotypes Among Healthcare-
Associated C. difficile Isolates, 2015 (n=614) Associated C. difficile Isolates, 2015 (n=538) 
Ribotype No of isolates % isolates
106 58 9%
027 52 8%
014 46 7%
020 40 7%
002 35 6%
015 21 3%
054 20 3%
005 19 3%
056 18 3%
046 17 3%
Others 288 47%
Ribotype No of isolates % isolates
027 102 19%
106 48 9%
002 40 7%
014 36 7%
020 30 6%
015 18 3%
001_072 17 3%
056 17 3%
017 15 3%
005 14 3%
Others 201 37%
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